The research development of STAT3 in hepatic ischemia-reperfusion injury

Front Immunol. 2023 Jan 24:14:1066222. doi: 10.3389/fimmu.2023.1066222. eCollection 2023.

Abstract

Ischemia-reperfusion injury (IRI) is a common complication of surgery, which can cause rapid deterioration of the liver function, increase the risk of graft rejection, and seriously affect the prognosis of patients. The signal transducer and activator of transcription 3 (STAT3) protein has been implicated in pathogenesis of IRI. STAT3 influences the mitochondria through multiple pathways and is also involved in apoptosis and other forms of programmed cell death. STAT3 is associated with Janus kinase (JAK), phosphoinositide-3 kinase (PI3K), and heme oxygenase-1 (HO-1) in liver IRI. The STAT3 pathway plays a dual role in IRI as it can also regulate lipid metabolism which may have potential for treating IRI fatty liver. In this review, we summarize research on the function of STAT3 in liver IRI to provide references for its application in the clinic.

Keywords: cell apoptosis; ischemia-reperfusion injury (IRI); liver; mitochondria; signal transducers and activators of transcription3 (STAT3).

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Humans
  • Janus Kinases / metabolism
  • Liver / pathology
  • Reperfusion Injury* / metabolism
  • STAT3 Transcription Factor* / metabolism
  • Signal Transduction / physiology

Substances

  • STAT3 Transcription Factor
  • Janus Kinases
  • STAT3 protein, human

Grants and funding

This study was supported by Hunan Provincial Natural Science Foundation of China (2022JJ40759 to PPZ,2022JJ30911 to YZ) and National Natural Science Foundation of China (82100695 to PZ)